Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2023
Monthly information related to total number of voting rights and shares composing the share capital…
News
Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2023
Monthly information related to total number of voting rights and shares composing the share capital…
XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial
AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) today began treating…
Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference
Trial investigators and company management to discuss latest data from the ReSPECT-LM leptomeningeal metastases clinical…
Clinetic Announces Series A Funding Round Led by Sopris Capital
DURHAM, N.C.–(BUSINESS WIRE)–Clinetic, a growing healthtech company focused on streamlining clinical research, today announced the…
When you need 5G service you can rely on, Verizon is there
The RootMetrics® State of 5G in the US Report again shows Verizon’s 5G network is…
Syncfusion Named as a Sample Vendor in the Gartner Hype Cycle™ for Finance Analytics, 2023
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) — Syncfusion, Inc., the enterprise technology…
Strata & Syntellis Coming Together to Accelerate Innovation and Deliver World-Class Service
CHICAGO, Aug. 08, 2023 (GLOBE NEWSWIRE) — Strata Decision Technology (Strata), a pioneer and leader…
Impact Launchpad Announces Agency Relationship with Carbotura to Eliminate Landfills Worldwide
Impact Launchpad to emphasize Carbotura’s jobs and economic impact program bringing non-governmental private investment to…
Trescon ABC: Embracing the Future of Innovation and Digital Transformation
SINGAPORE, Aug 8, 2023 – (ACN Newswire) – The World AI Show, World Blockchain Summit…
Quest Technology Management Wins Telarus Award as “Top Supplier for Cloud & Managed Services 2022”
Quest Technology Management is recognized for embracing the channel in delivery of successful solutions that…
Wolters Kluwer Offers Advisory Services to Address New Small Business Lending Requirements
Consulting resources help lenders navigate complexity of Section 1071 small business lending rule MINNEAPOLIS–(BUSINESS WIRE)–#WoltersKluwer–With…
Lightbeam Health Solutions Unleashes Creator Studio, A Data Customization Tool for Enhanced Healthcare Analytics
Lightbeam’s Creator Studio empowers healthcare professionals to access insights with unparalleled customization, enabling client-partners to…
Upland Panviva Now Available on Genesys AppFoundry
Panviva and Genesys Customer Experience Platform offering to deliver omnichannel knowledge for highly regulated industries…
Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure
Post-Hoc Analysis of SOLOIST-WHF Clinical Data Published in Journal of the American College of Cardiology:…
Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure
Post-Hoc Analysis of SOLOIST-WHF Clinical Data Published in Journal of the American College of Cardiology:…
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
Viracta Therapeutics Announces Publication in Blood Advances Demonstrating Promising and Durable Signal of Nana-val Efficacy in Patients with Relapsed or Refractory (R/R) Epstein-Barr Virus-Positive (EBV+) Lymphoma
Results from Phase 1b/2 trial showed complete responses achieved and ongoing durable responses observed out…
Viracta Therapeutics Announces Publication in Blood Advances Demonstrating Promising and Durable Signal of Nana-val Efficacy in Patients with Relapsed or Refractory (R/R) Epstein-Barr Virus-Positive (EBV+) Lymphoma
Results from Phase 1b/2 trial showed complete responses achieved and ongoing durable responses observed out…